咨询电话：010-67886402
化合物简介
Prasugrel (trade name Effient in the US and India, and Efient in the EU) is a pharmaceutical drug that acts as a platelet inhibitor and is used to prevent thrombosis (blood clotting). It was developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company.
Prasugrel was approved for use in Europe in February 2009, and in the US in July 2009, for the reduction of thrombotic cardiovascular events (including stent thrombosis) in people with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI).
Prasugrel was approved for use in Europe in February 2009, and in the US in July 2009, for the reduction of thrombotic cardiovascular events (including stent thrombosis) in people with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI).
基本信息
中文名称：普拉格雷盐酸盐中文别名：盐酸普拉格雷;
2-[2-(乙酰氧基)-6,7-二氢噻吩并[3,2-C]吡啶-5(4H)-基]-1-环丙基-2-(2-氟苯基)乙酮盐酸盐;英文名称：[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate,hydrochloride英文别名：Prasugrelhydrochloride;
Prasugren hydrochloride;
Prasugrel0 Hydrochloriden(Discontinued);CAS号：389574-19-0分子式：C20H21ClFNO3S分子量：409.90200精确质量：409.09100PSA：74.85000LogP：4.63090
2-[2-(乙酰氧基)-6,7-二氢噻吩并[3,2-C]吡啶-5(4H)-基]-1-环丙基-2-(2-氟苯基)乙酮盐酸盐;英文名称：[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate,hydrochloride英文别名：Prasugrelhydrochloride;
Prasugren hydrochloride;
Prasugrel0 Hydrochloriden(Discontinued);CAS号：389574-19-0分子式：C20H21ClFNO3S分子量：409.90200精确质量：409.09100PSA：74.85000LogP：4.63090
物化性质
沸点：493.5ºC at 760 mmHg
